[White] Announcement of Board of Directors' Resolution to Appoint Members of the Remuneration Committee
Key facts
- [White] Announcement of Board of Directors' Resolution to Appoint Members of the Remuneration Committee
- White Biotechnology's Board of Directors has resolved to re-appoint members of the Remuneration Committee upon the expiration of their terms. The new committee includes re-appointed members Lin Shui-Lung, Lai Shan-Kuei, and Wu Yung-Chang, with the addition of Cheng Chien-Hsin. This change is due to the expiration of the committee members' terms.
- Source: PR Times
- Date: June 9, 2026
Direct answer
White Biotechnology's Board of Directors has resolved to re-appoint members of the Remuneration Committee upon the expiration of their terms. The new committee includes re-appointed members Lin Shui-Lung, Lai Shan-Kuei, and Wu Yung-Chang, with the addition of Cheng Chien-Hsin. This change is due to the expiration of the committee members' terms.
- Citation
- [White] Announcement of Board of Directors' Resolution to Appoint Members of the Remuneration Committee (June 9, 2026), PR Times
- Source
- PR Times
- Date
- June 9, 2026
White Biotechnology's Board of Directors has resolved to re-appoint members of the Remuneration Committee upon the expiration of their terms. The new committee includes re-appointed members Lin Shui-Lung, Lai Shan-Kuei, and Wu Yung-Chang, with the addition of Cheng Chien-Hsin. This change is due to the expiration of the committee members' terms.
📋 Article Processing Timeline
- 📰 Published: June 9, 2026 at 09:00
- 🔍 Collected: June 10, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: June 12, 2026 at 17:53 (57h 53m after Collected)
2. Functional Committee Name: Remuneration Committee
3. Names of Former Members:
(1) Independent Director: Lin Shui-Lung
(2) Independent Director: Lai Shan-Kuei
(3) Independent Director: Wu Yung-Chang
4. Brief Biographies of Former Members:
(1) Independent Director: Lin Shui-Lung, Independent Director of the Company
(2) Independent Director: Lai Shan-Kuei, Independent Director of the Company
(3) Independent Director: Wu Yung-Chang, Independent Director of the Company
5. Names of New Members:
(1) Independent Director: Lin Shui-Lung
(2) Independent Director: Lai Shan-Kuei
(3) Independent Director: Wu Yung-Chang
(4) Independent Director: Cheng Chien-Hsin
6. Brief Biographies of New Members:
(1) Independent Director: Lin Shui-Lung, Independent Director of the Company
(2) Independent Director: Lai Shan-Kuei, Independent Director of the Company
(3) Independent Director: Wu Yung-Chang, Independent Director of the Company
(4) Independent Director: Cheng Chien-Hsin, Director and General Manager of San Fu Biomedical Co., Ltd.
7. Change Details (Please enter 'Resignation', 'Dismissal', 'Term Expiration', 'Death', or 'New Appointment'):
Term Expiration
8. Reason for Change: Term expiration, re-appointment by the Board of Directors.
9. Original Term (e.g., xx/xx/xx ~ xx/xx/xx): 112/05/24 ~ 115/05/23.
10. Effective Date of New Appointment: 115/06/09
11. Other Matters to be Noted: None.
FAQ
What is White Biotechnology's Remuneration Committee?
The Remuneration Committee is a subcommittee of the Board of Directors responsible for deliberating and deciding on matters related to executive compensation. At White Biotechnology, it is primarily composed of independent directors.
Why are the members of the Remuneration Committee changing?
The terms of the committee members have expired, leading the Board of Directors to decide on re-appointments and new appointments. This is a regular procedure within the company's governance framework.
Who is the new member, Cheng Chien-Hsin?
Mr. Cheng Chien-Hsin serves as the Director and General Manager of San Fu Biomedical Co., Ltd. He is expected to bring new perspectives and expertise.
Will this personnel change affect the company's performance?
A direct impact is currently unclear, but a stable compensation system and proper governance can contribute to long-term corporate value enhancement.
What are White Biotechnology's future business plans?
This announcement concerns the members of the Remuneration Committee; specific business development details are pending further disclosure. The company is advancing research and development in the biotechnology sector.